A review of clinical trials has shown that bronchodilators that contain inhaled beta-agonists like salmeterol (Advair) and albuterol increased the risk of death by nearly twice the rate of placebo in patients with chronic obstructive pulmonary disease (COPD). Another common type of bronchodilator, anticholinergics, reduced the incidence of respiratory-related deaths in COPD patients by 73 percent compared to placebo.
Read moreAn Overview In accordance with an international agreement to reduce ozone-depleting propellants, manufacturers of many inhalers have... Read more »
Asthma treatment is all about control. Control is the main goal of asthma treatment, as outlined in both the U.S. asthma management... Read more »
Many patients are prescribed inhaled corticosteroids for asthma control. With good reason, patients are concerned about the long term... Read more »
It's 2009, and that means we are all being forced to switch officially to the HFA type of asthma inhaler. Many other posts here have dealt... Read more »
By now many of you are aware of the arrival of HFA inhalers that represent the new environmental friendly carriers for aerosol inhalers.... Read more »
Fear of the needle is one of the main reasons many diabetics are reluctant to go on insulin, experts say, but two new delivery methods may relieve... Read more »
Drugmaker MAP Pharmaceuticals says that their inhaled migraine medication Levadex met all four of the study's goals in a recent clinical trial. The... Read more »
Corticosteroids are a good defense against asthma, but inhaling them brings a better outcome. According to a 16-week study of children ages 6 to 17,... Read more »
Asthma is a chronic inflammatory condition that causes the airways (bronchi) to produce excess mucus and close, making breathing difficult.... Read more »
This is a study to compare the safety and effectiveness of a combination of prandial inhaled insulin and metformin with the inhaled insulin and a... Read more »